Christina S. Chu, MD, on HPV and Cervical/Vulvar Cancer

2017 NCCN Annual Conference

Christina S. Chu, MD, of Fox Chase Cancer Center, discusses the link between human papillomavirus and genital cancers and what is known about the effect of HPV on treatment response and outcome.

Elizabeth R. Plimack, MD, on Bladder Cancer: Management Updates

Elizabeth R. Plimack, MD, of Fox Chase Canc...

Pancreatic Cancer

Margaret A. Tempero, MD, on Pancreatic Cancer: Active Systemic Treatment

Margaret A. Tempero, MD, of the UCSF Helen ...

Sarcoma

Suzanne George, MD, on Soft-Tissue Sarcoma: Evolving Treatment

Suzanne George, MD, of Dana-Farber Cancer I...

Lymphoma

Leo I. Gordon, MD, on Hodgkin Lymphoma: Management Strategies

Leo I. Gordon, MD, of the Robert H. Lurie C...

Hematologic Malignancies

Ruben A. Mesa, MD, on Myeloproliferative Neoplasms and Myelofibrosis: New Treatment Guidelines

Ruben A. Mesa, MD, of the Mayo Clinic Cance...

Feb

Today In Oncology

Christina S. Chu, MD, on HPV and Cervical/Vulvar Cancer

Related Videos

Elizabeth R. Plimack, MD, on Bladder Cancer: Management Updates

Margaret A. Tempero, MD, on Pancreatic Cancer: Active Systemic Treatment

Suzanne George, MD, on Soft-Tissue Sarcoma: Evolving Treatment

Leo I. Gordon, MD, on Hodgkin Lymphoma: Management Strategies

Ruben A. Mesa, MD, on Myeloproliferative Neoplasms and Myelofibrosis: New Treatment Guidelines

Familiarity With Complementary and Integrative Therapies Among Patients With Cancer and Caregivers

Two ADAURA Analyses Support the Use of Osimertinib in Patients With Surgically Resected NSCLC

Taiwanese TALENT Study Supports Effectiveness of Low-Dose CT for Lung Cancer in Certain Populations

New Burkitt Lymphoma International Prognostic Index

ASCO Names Advance of the Year: Molecular Profiling Drives Progress in Gastrointestinal Cancers